Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
JAMIA Open ; 6(4): ooad088, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37860603

ABSTRACT

Objectives: This study aimed to understand Black American women's attitudes toward seeking mental health services and using mobile technology to receive support for managing anxiety. Methods: A self-administered web-based questionnaire was launched in October 2019 and closed in January 2020. Women who identified as Black/African American were eligible to participate. The survey consisted of approximately 70 questions and covered topics such as, attitudes toward seeking professional psychological help, acceptability of using a mobile phone to receive mental health care, and screening for anxiety. Results: The findings of the study (N = 395) showed that younger Black women were more likely to have greater severity of anxiety than their older counterparts. Respondents were most comfortable with the use of a voice call or video call to communicate with a professional to receive support to manage anxiety in comparison to text messaging or mobile app. Younger age, higher income, and greater scores for psychological openness and help-seeking propensity increased odds of indicating agreement with using mobile technology to communicate with a professional. Black women in the Southern region of the United States had twice the odds of agreeing to the use of mobile apps than women in the Midwest and Northeast regions. Discussion: Black American women, in general, have favorable views toward the use of mobile technology to receive support to manage anxiety. Conclusion: Preferences and cultural appropriateness of resources should be assessed on an individual basis to increase likelihood of adoption and engagement with digital mental health interventions for management of anxiety.

3.
J Med Internet Res ; 25: e45766, 2023 07 19.
Article in English | MEDLINE | ID: mdl-37467027

ABSTRACT

BACKGROUND: Depression is a common mental health condition among Black American women. Many factors may contribute to the development of depressive symptoms, such as gender and racial discrimination, financial strain, chronic health conditions, and caregiving responsibilities. Barriers such as the stigmatization of mental illness, less access to treatment, the lack of or inadequate health insurance, mistrust of providers, and limited health literacy prevent marginalized populations from seeking care. Previous literature has shown that mobile health interventions are effective and can increase access to mental health services and resources. OBJECTIVE: We aimed to understand the attitudes and perceptions of Black women toward using mental health services and determine the acceptability and concerns of using mobile technology (ie, voice call, video call, SMS text messaging, and mobile app) to support the management of depression. METHODS: We launched a self-administered web-based questionnaire in October 2019 and closed it in January 2020. Women (aged ≥18 years) who identify as Black or African American or multiracial (defined as Black or African American and another race) were eligible to participate. The survey consisted of approximately 70 questions and included topics such as attitudes toward seeking professional psychological help, the acceptability of using a mobile phone to receive mental health care, and screening for depression. RESULTS: The findings (n=395) showed that younger Black women were more likely to have greater severity of depression than their older counterparts. The results also revealed that Black women have favorable views toward seeking mental health services. Respondents were the most comfortable with the use of voice calls or video calls to communicate with a professional to receive support for managing depression in comparison with SMS text messaging or mobile apps. The results revealed that higher help-seeking propensity increased the odds of indicating agreement with the use of voice calls and video calls to communicate with a professional to receive support for managing depression by 27% and 38%, respectively. However, no statistically significant odds ratios (all P>.05) were found between help-seeking propensity and respondents' agreement to use mobile apps or SMS text messaging. Moderate to severe depression severity increased the odds of using mobile apps to communicate with a professional to receive support for managing depression by 43%; however, no statistically significant odds ratios existed for the other modalities. Privacy and confidentiality, communication issues (eg, misinterpreting text), and the impersonal feeling of communicating by mobile phone (eg, SMS text messaging) were the primary concerns. CONCLUSIONS: Black American women, in general, have favorable views toward seeking mental health services and are comfortable with the use of mobile technology to receive support for managing depression. Future work should address the issues of access and consider the preferences and cultural appropriateness of the resources provided.


Subject(s)
Black or African American , Depression , Mental Health Services , Patient Acceptance of Health Care , Telemedicine , Adult , Female , Humans , Cross-Sectional Studies , Depression/therapy , Stereotyping , Surveys and Questionnaires
4.
Stud Health Technol Inform ; 290: 400-404, 2022 Jun 06.
Article in English | MEDLINE | ID: mdl-35673044

ABSTRACT

A majority of healthcare workers (HCWs) experience workplace violence (WPV) but most WPV events go unreported. Underreporting of WPV is well documented in the literature as a barrier to identifying underlying causes and to evaluating the effectiveness of WPV interventions. Previous studies suggest that WPV reporting data is fragmentary, unreliable, and inconsistent. Also, WPV reporting systems are suboptimally designed making it difficult for healthcare workers to report WPV incidents. This study aims to assess the usability of an electronic WPV report in a large academic medical center and the perceived cognitive workload (CWL) and performance of HCWs associated with reporting WPV events. Findings from this study suggest that our institutional WPV report has suboptimal perceived usability and suboptimal perceived cognitive workload. Further, participants with training reported lower error rates in comparison to participants without training on performance.


Subject(s)
Workplace Violence , Cognition , Electronics , Health Personnel/psychology , Humans , Surveys and Questionnaires , Workload , Workplace/psychology , Workplace Violence/psychology
5.
Stud Health Technol Inform ; 294: 58-62, 2022 May 25.
Article in English | MEDLINE | ID: mdl-35612016

ABSTRACT

Burnout in healthcare professionals (HCPs) is a multi-factorial problem. There are limited studies utilizing machine learning approaches to predict HCPs' burnout during the COVID-19 pandemic. A survey consisting of demographic characteristics and work system factors was administered to 450 HCPs during the pandemic (participation rate: 59.3%). The highest performing machine learning model had an area under the receiver operating curve of 0.81. The eight key features that best predicted burnout are excessive workload, inadequate staffing, administrative burden, professional relationships, organizational culture, values and expectations, intrinsic motivation, and work-life integration. These findings provide evidence for resource allocation and implementation of interventions to reduce HCPs' burnout and improve the quality of care.


Subject(s)
Burnout, Professional , COVID-19 , Burnout, Professional/diagnosis , Burnout, Professional/prevention & control , Burnout, Psychological , Delivery of Health Care , Health Personnel , Humans , Pandemics , Supervised Machine Learning
6.
Cancer ; 127(21): 3998-4005, 2021 11 01.
Article in English | MEDLINE | ID: mdl-34237155

ABSTRACT

BACKGROUND: The objective of this study was to describe bladder cancer outcomes as a function of race among patients with high-risk non-muscle-invasive bladder cancer (NMIBC) in an equal-access setting. METHODS: A total of 412 patients with high-risk NMIBC who received bacille Calmette-Guérin (BCG) from January 1, 2010, to December 31, 2015, were assessed. The authors used the Kaplan-Meier method to estimate event-free survival and Cox regression to determine the association between race and recurrence, progression, disease-specific, and overall survival outcomes. RESULTS: A total of 372 patients who had complete data were included in the analysis; 48 (13%) and 324 (87%) were Black and White, respectively. There was no difference in age, sex, smoking status, or Charlson Comorbidity Index by race. White patients had a higher socioeconomic status with a greater percentage of patients living above the poverty level in comparison with Black patients (median, 85% vs 77%; P < .001). A total of 360 patients (97%) received adequate induction BCG, and 145 patients (39%) received adequate maintenance BCG therapy. There was no significant difference in rates of adequate induction or maintenance BCG therapy according to race. There was no significant difference in recurrence (hazard ratio [HR], 1.53; 95% confidence interval [CI], 0.64-3.63), progression (HR, 0.77; 95% CI, 0.33-1.82), bladder cancer-specific survival (HR, 1.01; 95% CI, 0.30-3.46), or overall survival (HR, 0.97; 95% CI, 0.56-1.66) according to Black race versus White race. CONCLUSIONS: In this small study from an equal-access setting, there was no difference in the receipt of BCG or any differences in bladder cancer outcomes according to race.


Subject(s)
Urinary Bladder Neoplasms , Adjuvants, Immunologic , Administration, Intravesical , BCG Vaccine/therapeutic use , Humans , Neoplasm Invasiveness , Neoplasm Recurrence, Local/drug therapy , Progression-Free Survival , Proportional Hazards Models , Urinary Bladder
7.
JAMA Netw Open ; 4(3): e213800, 2021 03 01.
Article in English | MEDLINE | ID: mdl-33787908

ABSTRACT

Importance: Management of high-risk non-muscle-invasive bladder cancer (NMIBC) represents a clinical challenge due to high failure rates despite prior bacillus Calmette-Guérin (BCG) therapy. Objective: To describe real-world patient characteristics, long-term outcomes, and the economic burden in a population with high-risk NMIBC treated with BCG therapy. Design, Setting, and Participants: This retrospective cohort study identified 412 patients with high-risk NMIBC from 63 139 patients diagnosed with bladder cancer who received at least 1 dose of BCG within Department of Veterans Affairs (VA) centers across the US from January 1, 2000, to December 31, 2015. Adequate induction BCG therapy was defined as at least 5 installations, and adequate maintenance BCG therapy was defined as at least 7 installations. Data were analyzed from January 2, 2020, to January 20, 2021. Exposures: Intravesical BCG therapy, including adequate induction BCG therapy, was defined as at least 5 intravesical instillations of BCG within 70 days from BCG therapy start date. Adequate maintenance BCG therapy was defined as at least 7 installations of BCG within 274 days of the start (the first instillation) of adequate induction BCG therapy (ie, adequate induction BCG plus some form of additional BCG). Main Outcomes and Measures: The Kaplan-Meier method was used to estimate outcomes, including event-free survival. All-cause expenditures were summarized as medians with corresponding interquartile ranges (IQRs) and adjusted to 2019 USD. Results: Of the 412 patients who met inclusion criteria, 335 (81%) were male and 77 (19%) were female, with a median age of 67 (IQR, 61-74) years. Follow-up was 2694 person-years. A total of 392 patients (95%) received adequate induction BCG therapy, and 152 (37%) received adequate BCG therapy. For all patients with high-risk NMIBC, the 10-year progression-free survival rate and disease-specific death rate were 78% and 92%, respectively. Patients with carcinoma in situ (Cis) had worse disease-free survival than those without Cis (hazard ratio [HR], 1.85; 95% CI, 1.34-2.56). Total median costs at 1 year were $29 459 (IQR, $14 991-$52 060); at 2 years, $55 267 (IQR, $28 667-$99 846); and at 5 years, $117 361 (IQR, $59 680-$211 298). Patients with progressive disease had significantly higher median 5-year costs ($232 729 [IQR, $151 321-$341 195] vs $94 879 [IQR, $52 498-$172 631]; P < .001), with outpatient care, pharmacy, and surgery-related costs contributing. Conclusions and Relevance: Despite adequate induction BCG therapy, only 37% of patients received adequate BCG therapy. Patients with Cis had increased risk of progression, and progression regardless of Cis was associated with significantly increased costs relative to patients without progression. Extrapolating cost figures, regardless of progression, resulted in nationwide costs at 1 year of $373 million for patients diagnosed with high-risk NMIBC in 2019.


Subject(s)
BCG Vaccine/therapeutic use , Drug Costs , United States Department of Veterans Affairs/statistics & numerical data , Urinary Bladder Neoplasms/drug therapy , Veterans/statistics & numerical data , Adjuvants, Immunologic/economics , Adjuvants, Immunologic/therapeutic use , Aged , BCG Vaccine/economics , Disease-Free Survival , Drug Administration Schedule , Female , Follow-Up Studies , Humans , Male , Middle Aged , Retrospective Studies , Time Factors , United States , Urinary Bladder Neoplasms/diagnosis , Urinary Bladder Neoplasms/economics
SELECTION OF CITATIONS
SEARCH DETAIL
...